Standing Ovation essentially replicates caseins in a lab setting, and it achieves this through a “precision fermentation” process to recreate what is a core ingredient for non-animal, lactose-free dairy substitutes.
Standing Ovation has raised €49M across 4 funding rounds from 15 investors, most recently a Series B round in Mar 2026. Based in Paris, France; active in Foodtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-03-31 | Series B | €30M | Angelor,Astanor Ventures,Bel Group,Big Idea Ventures,Crédit Mutuel Innovation,Danone Ventures+5 more | View deal → |
| 2024-09-13 | Series A | €3.8M | Astanor Ventures,Bel Group,Big Idea Ventures,Bpifrance,Good Startup ,Peakbridge+1 more | View deal → |
| 2024-01-10 | Other | €3.0M | Bpifrance,Green Invest EU | View deal → |
| 2022-09-14 | Series A | €12M | Astanor Ventures,Big Idea Ventures,Good Startup ,Peakbridge,Seventure Partners | View deal → |
